Download FREE Sample
Overview
Photon-counting computed tomography (PCCT) is a novel technology that allows higher spatial resolution as compared to conventional CT techniques resulting in improved spatial resolution, enhanced tissue contrast, and minimized image noise while retaining energy specific information. Compared to conventional CT, it provides similar dose reduction, specific material differentiation, and reduced contrast resolution; making it highly desirable for advanced imaging of diagnostic value in oncology, cardiology, and neurology areas. Overall photon counting CT represents a significant leap in diagnostic imaging technology.
To learn more about this report, download the PDF brochure
Superior image quality and resolution to drive market growth
The ability to provide superior image quality and resolution is a key factor contributing to the growth of the PCCT market because it will significantly improve diagnostic accuracy. PCCT technology utilizes advanced detectors that count individual X-ray photons and store their energy information. This yields greater spatial resolution and improved contrast-to-noise ratio compared to conventional CT systems, resulting in the superior depiction of small anatomical structures and subtle lesions, which is valuable when detecting early-stage cancers, cardiovascular abnormalities, and neurological disorders. The use of photon counting CT is likely to become more prevalent in clinical practice because of its ability to provide sharper and more defined images compared to conventional systems, thereby improving patient care, patient outcomes, and clinical confidence.
Increased research and clinical validation to boost market growth
Various large medical imaging device manufacturers like Siemens Healthineers, GE HealthCare, and Canon Medical Systems among others are realizing the transformative potential of the technology and hence actively investing in or developing PCCT systems. For instance, in 2021, Siemens Healthineers launched and received FDA approval for its Naeotom Alpha, world-s first commercially approved PCCT system, thus setting a benchmark and opening the market. In 2024, Canon Medical Systems Corporation and Canon Healthcare USA, Inc. entered into a research collaboration with Penn Medicine for speeding the development of PCCT. In 2020, GE Healthcare acquired Prismatic Sensors, a Swedish start-up company having expertise in photon counting detectors, to strengthen their position in this market. The increased participation by both established and new imaging companies is a major contributor to the growth of the Pet, as it is driving innovation, increasing accessibility and moving photon counting CT from a research innovation to a mainstream diagnostic modality.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global photon counting CT market is marked by the presence of established and emerging market players such as Siemens Healthineers AG; GE Healthcare; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Shanghai United Imaging Healthcare Co., LTD; Samsung; and Hitachi; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~20% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Type, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Siemens Healthineers AG; GE Healthcare; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Shanghai United Imaging Healthcare Co., LTD; Samsung; and Hitachi; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Photon Counting Computed Tomography (CT) Market Segmentation
This report by Medi-Tech Insights provides thesize of the global photon counting CT market at theregional- and country-level from 2023 to 2030. The report further segments the market based on type, application, and end user.
Market Size & Forecast (2023-2030), By Technology, USD Million
- Single Detector PCCT
- Dual-Detector PCCT
- Multidetector PCCT
Market Size & Forecast (2023-2030), By Application, USD Million
- Oncology
- Cardiology
- Neurology
- Pulmonology
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Diagnostic Imaging Centers
- Others
Market Size & Forecast (2023-2030SD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the photon counting CT market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the photon counting CT market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
